Natus Medical Incorporated

NasdaqGS:NTUS Stock Report

Market Cap: US$1.1b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Natus Medical Future Growth

Future criteria checks 3/6

Key information

58.9%

Earnings growth rate

58.1%

EPS growth rate

Medical Equipment earnings growth16.6%
Revenue growth rate4.4%
Future return on equityn/a
Analyst coverage

Low

Last updatedn/a

Recent future growth updates

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

May 05
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Jan 11
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Recent updates

Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600

Jul 22

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Mar 04
Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Nov 08
Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit

Aug 13
We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit

Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

Aug 02
Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now

Jun 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

May 05
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?

Feb 15
Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Jan 11
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years

Dec 07
Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years

Earnings and Revenue Growth Forecasts

NasdaqGS:NTUS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202351745N/AN/A1
12/31/202249534N/AN/A1
3/31/2022478134448N/A
12/31/2021473136064N/A
9/30/2021464176569N/A
6/30/202145226569N/A
3/31/2021421-113642N/A
12/31/2020416-172634N/A
9/30/2020428-192029N/A
6/30/2020449-13646N/A
3/31/2020490116471N/A
12/31/2019495-165560N/A
9/30/2019505-305562N/A
6/30/2019512-443846N/A
3/31/2019517-502533N/A
12/31/2018531-232433N/A
9/30/2018521-181724N/A
6/30/2018513-211421N/A
3/31/2018505-241925N/A
12/31/2017501-201620N/A
9/30/2017477-31518N/A
6/30/2017445194750N/A
3/31/2017419345255N/A
12/31/2016382436973N/A
9/30/2016374416770N/A
6/30/2016378394650N/A
3/31/2016374383742N/A
12/31/201537638N/A37N/A
9/30/201537040N/A44N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NTUS's forecast earnings growth (58.9% per year) is above the savings rate (1.9%).

Earnings vs Market: NTUS's earnings (58.9% per year) are forecast to grow faster than the US market (13.1% per year).

High Growth Earnings: NTUS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NTUS's revenue (4.4% per year) is forecast to grow slower than the US market (8% per year).

High Growth Revenue: NTUS's revenue (4.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NTUS's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/07/22 19:55
End of Day Share Price 2022/07/20 00:00
Earnings2022/03/31
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Natus Medical Incorporated is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Raymond MyersBenchmark Company
Lawrence SolowCJS Securities, Inc.